KLRC1 and neoplasm: Meanwhile, the KLRD1-NKG2 complex can clear tumor cells by increasing NK cell activation and killing, as well as preventing T-cell attack on their own tissues by suppressing T-cell immunity, so several drugs targeting the KLRD1-NKG2 complex are in research or clinical trials 19.